Is a complete AIM/CRTX research report available?

No complete published report is available for aim/CRTX (AIM/CRTX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

AIM/CRTX (AIM/CRTX)

London Stock Exchange AIM: AIM/CRTX · GBX

GBX 10.6

-0.70 (-6.2%)· Recorded snapshot

Market cap	6.1M
Revenue (ttm)	231K
Net income (ttm)	-1.9M
EPS (ttm)	-GBX 0.05
Shares out	54.2M
Volume	9,259
Beta	0.58

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 231K
Net income (ttm): -1.9M
EPS (ttm): -GBX 0.05
Market cap: 6.1M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-11 02:00 UTC

All AIM/CRTX indicators

Market & fundamental data

Available fields

177

Groups with data

Currency

GBP

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	British Virgin Islands
Country code	UK
Employees	4
Employees Change	-12%
Employees Change Percent	-75
Enterprise value	GBX 5M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	VGG042401262
Last refreshed	2026-09-11
Market cap	GBX 6.1M
Price	GBX 10.55
Price currency	GBX
Rev Per Employee	57,750x
Sector	Healthcare
Sector PE	21.2
Sector PE Fwd	13.53
Sic	2836
Symbol	aim/CRTX
Website	https://www.crismtherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-31.19%
EV/Sales	21.53x
FCF yield	-32.24%
P/B ratio	4.31x
P/S ratio	26.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	56.71%
Gross Profit	GBX 131,000
Gross Profit Growth	907.69%
Net Income	GBX -1.9M
Net Income Growth Years	0%
Pretax Margin	-812.99%
Profit Per Employee	GBX -475,750
ROA	-64.97
Roa5y	-26.13
ROCE	-132.6
ROE	-129.8
Roe5y	-56.43
ROIC	-81.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-1.53%
Cagr15y	-7.64%
Cagr1y	0.48%
Cagr20y	-9.35%
Cagr3y	-9.85%
Cagr5y	8.69%
EPS Growth Years	1
Revenue Growth	413.33x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.13
Assets	GBX 1.8M
Cash	GBX 1.1M
Current Assets	GBX 1.7M
Current Liabilities	GBX 381,000
Debt	GBX 0
Equity	GBX 1.4M
Liabilities	GBX 381,000
Long Term Assets	GBX 140,000
Long Term Liabilities	GBX 0
Net Cash	GBX 1.1M
Net Cash By Market Cap	GBX 18.49
Net Cash Growth	-12.01%
Net Debt Equity	GBX -0.8
Tangible Book Value	GBX 1.3M
Tangible Book Value Per Share	GBX 0.03
WACC	7.46

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.35
Net Working Capital	GBX 148,000
Quick ratio	3.6
Working Capital	GBX 1.3M
Working Capital Turnover	GBX 0.18

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-500.23%
Dividend per share	GBX 0
Last Dividend	GBX 2.88

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-14.32%
1Y total return	0.48%
200-day SMA	11.3
3Y total return	-26.74%
50-day SMA	10.37
50-day SMA vs 200-day SMA	50under200
5Y total return	51.66%
All Time High	7,132.8
All Time High Change	-99.85%
All Time High Date	2015-06-15
All Time Low	5
All Time Low Change	111%
All Time Low Date	2024-06-19
ATR	0.96
Beta	0.58
Beta1y	0.04
Beta2y	0.2
Ch YTD	5.5
High	12
High52	18.5
High52 Date	2026-02-19
High52ch	-42.97%
Low	10.5
Low52	8
Low52 Date	2025-12-16
Low52ch	31.88%
Ma50ch	1.74%
Price vs 200-day SMA	-6.6%
RSI	70.99
RSI Monthly	39.96
RSI Weekly	51.66
Sharpe ratio	0.69x
Sharpe Ratio3y	0.64x
Sharpe Ratio5y	0.55x
Sortino ratio	1.24
Sortino Ratio3y	3.34
Sortino Ratio5y	2.25
Total Return	-500.23%
Tr YTD	5.5
Tr15y	-69.67%
Tr1m	11.05%
Tr1w	-6.22%
Tr3m	-4.09%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	31,889,418%
Shares Insiders	38.46%
Shares Institutions	17.52%
Shares Out	54,235,266
Shares Qo Q	23.19%
Shares Yo Y	500.23%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	296,942.25x
Bv Per Share	0.03
Ch10y	-98.14
Ch15y	-99.34
Ch1m	11.05
Ch1w	-6.22
Ch1y	0.48
Ch20y	-99.69
Ch3m	-4.09
Ch3y	-26.74
Ch5y	-96.7
Ch6m	-12.08
Change	-6.22%
Change From Open	0.48
Close	11.25
Days Gap	-6.67
Depreciation Amortization	17,000
Dollar Volume	97,682.5
Earnings Date	2026-09-17
EBIT	GBX -1.9M
EBITDA	GBX -1.9M
EPS	GBX -0.05
F Score	2
FCF	GBX -2M
FCF EV Yield	-39.55x
FCF Per Share	GBX -0.04
Financing CF	1,843,000
Fiscal Year End	December
Founded	2,016
Income Tax	GBX -2,000
Investing CF	-31,000
Is Primary Listing	1
Last Earnings Date	2025-12-23
Last Report Date	2025-12-31
Last Split Date	2024-05-31
Last Split Type	Reverse
Ma150	11.55
Ma150ch	-8.63%
Ma20	11.21
Ma20ch	-5.91%
Net CF	-154,000
Next Earnings Date	2026-09-17
Open	10.5
Position In Range	3.33
Ppne	36,000
Price Date	2026-09-10
Ptbv Ratio	4.65
Relative Volume	0.03x
Revenue	231,000x
Tax By Revenue	-0.87x
Tr20y	-85.95%
Tr6m	-12.08%
Volume	9,259
Z Score	1.33

AIM/CRTX (AIM/CRTX)

Price

Financial snapshot

Fair-value bridge

Latest news · AIM/CRTX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AIM/CRTX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on AIM/CRTX

Frequently asked questions